Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
International Journal of Cancer|September 26, 2025
New cell lines expanding the diversity of Ewing sarcoma modelsMaximilian Kerkhoff, Christiane Schaefer, Wilhelm G Dirks, et al.
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
British Journal of Cancer|June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumoursTill Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemiaEmma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Journal of Neuro-Oncology|April 17, 2024
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokinesDaniela Kocher, Lei Cao, Romain Guiho, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
Pageof 1